These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 25392857)

  • 1. Viral load versus CD4⁺ monitoring and 5-year outcomes of antiretroviral therapy in HIV-positive children in Southern Africa: a cohort-based modelling study.
    Salazar-Vizcaya L; Keiser O; Karl Technau ; Davies MA; Haas AD; Blaser N; Cox V; Eley B; Rabie H; Moultrie H; Giddy J; Wood R; Egger M; Estill J
    AIDS; 2014 Oct; 28(16):2451-60. PubMed ID: 25392857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failure.
    Davies MA; Boulle A; Technau K; Eley B; Moultrie H; Rabie H; Garone D; Giddy J; Wood R; Egger M; Keiser O;
    Trop Med Int Health; 2012 Nov; 17(11):1386-90. PubMed ID: 22974345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis.
    Haas AD; Keiser O; Balestre E; Brown S; Bissagnene E; Chimbetete C; Dabis F; Davies MA; Hoffmann CJ; Oyaro P; Parkes-Ratanshi R; Reynolds SJ; Sikazwe I; Wools-Kaloustian K; Zannou DM; Wandeler G; Egger M;
    Lancet HIV; 2015 Jul; 2(7):e271-8. PubMed ID: 26423252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of immunological criteria for identifying virological failure in children on antiretroviral therapy - the IeDEA Southern Africa Collaboration.
    Davies MA; Boulle A; Eley B; Moultrie H; Technau K; Rabie H; van Cutsem G; Giddy J; Wood R; Egger M; Keiser O;
    Trop Med Int Health; 2011 Nov; 16(11):1367-71. PubMed ID: 21834797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ and viral load outcomes of antiretroviral therapy switch strategies after virologic failure of combination antiretroviral therapy in perinatally HIV-infected youth in the United States.
    Fairlie L; Karalius B; Patel K; van Dyke RB; Hazra R; Hernán MA; Siberry GK; Seage GR; Agwu A; Wiznia A;
    AIDS; 2015 Oct; 29(16):2109-19. PubMed ID: 26182197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV: an international cohort collaboration.
    Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration
    Lancet HIV; 2019 Feb; 6(2):e105-e115. PubMed ID: 30723008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ gain percentile curves for monitoring response to antiretroviral therapy in HIV-infected adults.
    Yotebieng M; Maskew M; Van Rie A
    AIDS; 2015 Jun; 29(9):1067-75. PubMed ID: 26125140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extending Visit Intervals for Clinically Stable Patients on Antiretroviral Therapy: Multicohort Analysis of HIV Programs in Southern Africa.
    Haas AD; Johnson LF; Grimsrud A; Ford N; Mugglin C; Fox MP; Euvrard J; van Lettow M; Prozesky H; Sikazwe I; Chimbetete C; Hobbins M; Kunzekwenyika C; Egger M;
    J Acquir Immune Defic Syndr; 2019 Aug; 81(4):439-447. PubMed ID: 31242142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virologic response of treatment experienced HIV-infected Ugandan children and adolescents on NNRTI based first-line regimen, previously monitored without viral load.
    Kibalama Ssemambo P; Nalubega-Mboowa MG; Owora A; Serunjogi R; Kironde S; Nakabuye S; Ssozi F; Nannyonga M; Musoke P; Barlow-Mosha L
    BMC Pediatr; 2021 Mar; 21(1):139. PubMed ID: 33752636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring.
    ; Keiser O; Tweya H; Boulle A; Braitstein P; Schecter M; Brinkhof MW; Dabis F; Tuboi S; Sprinz E; Pujades-Rodriguez M; Calmy A; Kumarasamy N; Nash D; Jahn A; MacPhail P; Lüthy R; Wood R; Egger M
    AIDS; 2009 Sep; 23(14):1867-74. PubMed ID: 19531928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited.
    Orrell C; Harling G; Lawn SD; Kaplan R; McNally M; Bekker LG; Wood R
    Antivir Ther; 2007; 12(1):83-8. PubMed ID: 17503751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria.
    van Oosterhout JJ; Brown L; Weigel R; Kumwenda JJ; Mzinganjira D; Saukila N; Mhango B; Hartung T; Phiri S; Hosseinipour MC
    Trop Med Int Health; 2009 Aug; 14(8):856-61. PubMed ID: 19552661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detecting virological failure in HIV-infected Tanzanian children.
    Mgelea EM; Kisenge R; Aboud S
    S Afr Med J; 2014 Jun; 104(10):696-9. PubMed ID: 25363057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial.
    ARROW Trial team
    Lancet; 2013 Apr; 381(9875):1391-1403. PubMed ID: 23473847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained virological response on second-line antiretroviral therapy following virological failure in HIV-infected patients in rural South Africa.
    Schoffelen AF; Wensing AM; Tempelman HA; Geelen SP; Hoepelman AI; Barth RE
    PLoS One; 2013; 8(3):e58526. PubMed ID: 23505529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of switch to paediatric second-line antiretroviral therapy after first-line failure in Cameroon.
    Njom-Nlend AE; Efouba N; Brunelle Sandie A; Fokam J
    Trop Med Int Health; 2021 Aug; 26(8):927-935. PubMed ID: 33905593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How do different eligibility guidelines for antiretroviral therapy affect the cost-effectiveness of routine viral load testing in sub-Saharan Africa?
    Scott Braithwaite R; Nucifora KA; Toohey C; Kessler J; Uhler LM; Mentor SM; Keebler D; Hallett T
    AIDS; 2014 Jan; 28 Suppl 1(0 1):S73-83. PubMed ID: 24468949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4 criteria improves the sensitivity of a clinical algorithm developed to identify viral failure in HIV-positive patients on antiretroviral therapy.
    Evans DH; Fox MP; Maskew M; McNamara L; MacPhail P; Mathews C; Sanne I
    J Int AIDS Soc; 2014; 17(1):19139. PubMed ID: 25227265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ T-cell Count may not be a Useful Strategy to Monitor Antiretroviral Therapy Response in HTLV-1/HIV Co-infected Patients.
    Vandormael A; Rego F; Danaviah S; Carlos Junior Alcantara L; Boulware DR; de Oliveira T
    Curr HIV Res; 2017; 15(3):225-231. PubMed ID: 28215175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of durability of first-line antiretroviral therapy regimen and time from first-line failure to second-line antiretroviral therapy initiation.
    Desmonde S; Eboua FT; Malateste K; Dicko F; Ekouévi DK; Ngbeché S; Koueta F; Sy HS; Renner L; Koumakpai SA; Leroy V;
    AIDS; 2015 Jul; 29(12):1527-36. PubMed ID: 26244392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.